TY - JOUR
T1 - Far-infrared absorption studies in MeV C+ and C2+ implanted InSb (111) crystals
AU - Yang, T. R.
AU - Kuri, G.
AU - Lu, C. C.
PY - 2000
Y1 - 2000
N2 - In this work, we briefly report on far-infrared absorption (FIR) studies on MeV C+ and C2+ implanted InSb crystals in order to investigate the quality of the implanted layers and the basic difference in the C+ and C2+ implantations. It is found from the FIR data that, in C2+ implanted InSb samples, the transverse optical mode profile is broadened as compared to the samples implanted with C+ at the same energy/atoms and at a constant fluence. A detailed analysis shows that the conductivity in C2+ irradiated specimen is enhanced compared to the C+ implantation. The results are attributed to the non-linear damage distribution due to C2+ and the substitutional lattice site occupation of the implanted C atoms.
AB - In this work, we briefly report on far-infrared absorption (FIR) studies on MeV C+ and C2+ implanted InSb crystals in order to investigate the quality of the implanted layers and the basic difference in the C+ and C2+ implantations. It is found from the FIR data that, in C2+ implanted InSb samples, the transverse optical mode profile is broadened as compared to the samples implanted with C+ at the same energy/atoms and at a constant fluence. A detailed analysis shows that the conductivity in C2+ irradiated specimen is enhanced compared to the C+ implantation. The results are attributed to the non-linear damage distribution due to C2+ and the substitutional lattice site occupation of the implanted C atoms.
KW - InSb
KW - Infrared absorption
KW - Ion implantation doping
UR - http://www.scopus.com/inward/record.url?scp=0033688693&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033688693&partnerID=8YFLogxK
U2 - 10.1016/S0921-4526(99)02991-9
DO - 10.1016/S0921-4526(99)02991-9
M3 - Article
AN - SCOPUS:0033688693
SN - 0921-4526
VL - 284-288
SP - 2103
EP - 2104
JO - Physica B: Condensed Matter
JF - Physica B: Condensed Matter
IS - PART II
ER -